272 related articles for article (PubMed ID: 28422718)
1. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
Hwang SM; Lee KC; Lee MS; Park KU
Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
Shin S; Hwang IS; Lee ST; Choi JR
Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
[TBL] [Abstract][Full Text] [Related]
6. Improving indel detection specificity of the Ion Torrent PGM benchtop sequencer.
Yeo ZX; Chan M; Yap YS; Ang P; Rozen S; Lee AS
PLoS One; 2012; 7(9):e45798. PubMed ID: 23029247
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes.
Yeo ZX; Wong JC; Rozen SG; Lee AS
BMC Genomics; 2014 Jun; 15(1):516. PubMed ID: 24962530
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.
Vendrell JA; Vilquin P; Larrieux M; Van Goethem C; Solassol J
J Mol Diagn; 2018 Nov; 20(6):754-764. PubMed ID: 30055349
[TBL] [Abstract][Full Text] [Related]
9. Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model.
Tarabeux J; Zeitouni B; Moncoutier V; Tenreiro H; Abidallah K; Lair S; Legoix-Né P; Leroy Q; Rouleau E; Golmard L; Barillot E; Stern MH; Rio-Frio T; Stoppa-Lyonnet D; Houdayer C
Eur J Hum Genet; 2014 Apr; 22(4):535-41. PubMed ID: 23942203
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
12. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.
Dacheva D; Dodova R; Popov I; Goranova T; Mitkova A; Mitev V; Kaneva R
Mol Diagn Ther; 2015 Apr; 19(2):119-30. PubMed ID: 25893891
[TBL] [Abstract][Full Text] [Related]
13. Significant allelic dropout phenomenon of Oncomine BRCA Research Assay on Ion Torrent S5.
Jeong TD; Cho SY; Kim MW; Huh J
Clin Chem Lab Med; 2019 May; 57(6):e124-e127. PubMed ID: 30367782
[No Abstract] [Full Text] [Related]
14. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
Trujillano D; Weiss ME; Schneider J; Köster J; Papachristos EB; Saviouk V; Zakharkina T; Nahavandi N; Kovacevic L; Rolfs A
J Mol Diagn; 2015 Mar; 17(2):162-70. PubMed ID: 25556971
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.
Feliubadaló L; Lopez-Doriga A; Castellsagué E; del Valle J; Menéndez M; Tornero E; Montes E; Cuesta R; Gómez C; Campos O; Pineda M; González S; Moreno V; Brunet J; Blanco I; Serra E; Capellá G; Lázaro C
Eur J Hum Genet; 2013 Aug; 21(8):864-70. PubMed ID: 23249957
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.
Buzolin AL; Moreira CM; Sacramento PR; Oku AY; Fornari ARDS; Antonio DSM; Quaio CRDAC; Baratela WR; Mitne-Neto M
Hum Genomics; 2017 Jun; 11(1):14. PubMed ID: 28651617
[TBL] [Abstract][Full Text] [Related]
17. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
18. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
[TBL] [Abstract][Full Text] [Related]
19. A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.
Scaglione GL; Concolino P; De Bonis M; De Paolis E; Minucci A; Ferrandina G; Scambia G; Capoluongo E
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570666
[No Abstract] [Full Text] [Related]
20. Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection.
Capone GL; Putignano AL; Trujillo Saavedra S; Paganini I; Sestini R; Gensini F; De Rienzo I; Papi L; Porfirio B
J Mol Diagn; 2018 Jan; 20(1):87-94. PubMed ID: 29061375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
